Avastin

Bio & Pharma Celltrion’s Vegzelma listed on US PBM preferred drug list

South Korea's Celltrion Healthcare Co. announced on Tuesday that its anti-cancer biosimilar Vegzelma (active ingredient: bevacizumab) was listed as ...

Bio & Pharma Celltrion gains sales approval for biosimilar Vegzelma in Europe

Celltrion Healthcare Co., South Korean biopharmaceutical giant Celltrion Inc.'s global marketing affiliate, said on Friday it has obtained the Europ...